ArticleScientific reports2025
Integrating convolutional layers and biformer network with forward-forward and backpropagation training.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- MolGramTreeNet: A multimodal molecular property prediction model via grammar tree-constrained molecular representation.iScience · 2026Article
- Exploring potential transcription factors and their regulatory relationships based on asymmetric covariance natural vector encoding method and machine learning algorithms.Briefings in bioinformatics · 2026Article
- RA-PLA: Retrieval-augmented graph convolutional networks for protein-ligand binding affinity prediction.PloS one · 2026Article
- scDIFF: automatic cell type annotation using scATAC-seq data by incorporating bulk-level genomic and epigenomic information in a deep diffusive transformer.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate molecular property prediction is crucial for drug discovery and computational chemistry, facilitating the identification of promising compounds and accelerating therapeutic development. Traditional machine learning falters with high-dimensional data and manual feature engineering, while existing deep learning approaches may not capture complex molecular structures, leaving a research gap. We introduce Deep-CBN, a novel framework designed to enhance molecular property prediction by capturing intricate molecular representations directly from raw data, thus improving accuracy and efficiency. Our methodology combines convolutional neural networks (CNNs) with a BiFormer attention mechanism, employing both the forward-forward algorithm and backpropagation. The model operates in three stages: (1) feature learning, extracting local features from SMILES strings using CNNs; (2) attention refinement, capturing global context with a BiFormer module enhanced by the forward-forward algorithm; and (3) prediction subnetwork tuning, fine-tuning via backpropagation. Evaluations on benchmark datasets-including Tox21, BBBP, SIDER, ClinTox, BACE, HIV, and MUV-show that Deep-CBN achieves near-perfect ROC-AUC scores, significantly outperforming state-of-the-art methods. These findings demonstrate its effectiveness in capturing complex molecular patterns, offering a robust tool to accelerate drug discovery processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.